Lorus Therapeutics Signs Research and License Option Agreement With Elanco
April 17, 2013 07:00 ET
|
Lorus Therapeutics Inc.
TORONTO, April 17, 2013 (GLOBE NEWSWIRE) -- Lorus Therapeutics Inc. (TSX:LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical products...
Lorus Therapeutics Announces Presentation of Biomarker Data for LOR-253 at 2013 AACR Annual Meeting
April 10, 2013 07:00 ET
|
Lorus Therapeutics Inc.
TORONTO, April 10, 2013 (GLOBE NEWSWIRE) -- Lorus Therapeutics Inc. (TSX:LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical products...